Skip to content
Search

Latest Stories

Costs and Accessibility of MSC Therapy for Parkinson’s Disease

Exploring Mesenchymal Stem Cells and Their Accessibility in Parkinson’s Disease Treatment

Parkinson’s disease is a progressive neurodegenerative disorder in which the patient has various motor symptoms. In the later Parkinson’s disease stages, the motor symptoms worsen, and the patient also develops nonmotor symptoms. 

Parkinson’s disease is believed to be caused due to the loss of dopaminergic neurons in the substantia nigra pars compacta, which is part of the basal ganglia. The loss of neurons leads to movement slowing, as seen in Parkinson’s disease. Patients with Parkinson’s disease have characteristic symptoms such as bradykinesia (slow movements), rigidity, resting tremors, walking instability, and falls. Some non-motor symptoms include expressionless faces, sleep disturbances, depression, and cognitive decline. 


Although the mechanism of Parkinson’s disease is understood to a certain extent, the current treatments only slow down the process for a bit before becoming ineffective. But with stem cells, researchers hope to change the landscape of Parkinson’s disease treatment options and hopefully provide patients with an option that not only significantly slows down disease progression but also manages to improve them.

Understanding the Financial Aspects of MSC Therapy for Parkinson’s Disease

Mesenchymal stem cell therapy is not new, but its use for Parkinson’s disease is somewhat new. It is also more costly than the normally used treatment options, oral medicines. 

MSC therapy requires a lot of steps and procedures, and to ensure the procedure's safety, a lot of money is spent on the technology. MSC is not as simple as extracting and injecting cells into the patient. Some various steps and conditions need to be taken care of. 

When the cells are extracted, whether from the patient or the donor, they must be extracted carefully and in a sterile environment. Then, they must be cultured with the appropriate growth factor before being injected into the patient. If, at any point, something goes wrong, the entire procedure fails. So, higher costs also ensure higher success rates. 

The cost is not just for the procedure but also for evaluations before and after the procedure. So, patients must spend money to get tested to ensure they are suitable candidates. After the procedure, they must follow up with the doctor regularly to ensure that everything is going to plan. All this adds to the cost, too. 

What factors determine the cost of MSC Therapy for Parkinson’s Disease?

Like any treatment option, various factors determine the cost of stem cell therapy for Parkinson’s disease. Five significant factors influence the cost of the therapy. These factors are –

  1. The type of cells used.
  2. The sourcing of the cells.
  3. The number of cells acquired.
  4. The lab in which the cells are cultured.
  5. The quality of the cells used. 

Adult stem cells, such as mesenchymal stem cells, are cheaper than embryonic stem cells, but the cost is still high. These procedures are also conducted in highly regulated and top-of-the-line labs and facilities, which further adds to the cost of the procedure. 

Unlike a simple procedure for localized pain, the injection of stem cells for Parkinson’s disease is more complex, adding to the cost. 

Does insurance cover MSC Therapy for Parkinson’s Disease treatment?

Currently, very few stem cell therapies are covered by insurance, and unfortunately, stem cell therapy for Parkinson’s disease is not one of them. However, you should consult various insurance providers to see what can be done.

How accessible is MSC Therapy for Parkinson’s Disease?

Since using stem cells to treat Parkinson’s disease is new, the therapy is not available as widely as some other stem cell therapies. It is also not available for patients at all Parkinson’s disease stages, as the results are better when treatment is undergone at an earlier stage. 

But, there are still various places conducting this treatment that can produce promising results. You can find even more information about it by consulting experts at Swiss Medica Clinics.

What are the potential financial and logistical challenges of pursuing MSC Therapy for Parkinson’s Disease?

One of the biggest hurdles from a patient’s perspective is the cost of the therapy. It is also not a simple procedure that can be done in a single day and requires a lot of testing and follow-up visits. 

Even if the cells are taken from the patient themselves, the procedures are rather complex and require a lot of technology, optimum storage, and working conditions to ensure the best results. The injection of these cells into the patient after being replicated is also a complex task and requires a lot of expertise. So, the procedure is only offered by a handful of reputable institutes. 

Affordability and Accessibility of Mesenchymal Stem Cell Therapy for Parkinson’s Disease

Neurodegenerative diseases like Parkinson’s disease can be very difficult for both the patient and their family. But with advancements in science and new treatment options like stem cell therapy, there is hope for these patients. 

Although the cost of stem cells to treat Parkinson’s disease are not minimal, the results can be rather promising. They can help improve the patient’s quality of life rather significantly. If you are in need of such a treatment, you can check out one of the most prominent clinics in this field, Swiss Medica in order to receive more information.

More For You

Campbell Wilson

Air India CEO Campbell Wilson steps down as Air India Express chair

Air India CEO Campbell Wilson steps down as Air India Express chair

AIR INDIA CEO Campbell Wilson is stepping down as chair of Air India Express, the airline’s low-cost subsidiary. He will be replaced by Nipun Aggarwal, Air India’s chief commercial officer, according to an internal memo sent on Tuesday.

Wilson will also step down from the board of Air India Express. Basil Kwauk, Air India’s chief operating officer, will take his place.

Keep ReadingShow less
Harry and Meghan urge tougher safeguards to protect children online

Prince Harry criticised tech companies for citing privacy laws to deny access

Getty

Harry and Meghan urge tougher safeguards to protect children online

The Duke and Duchess of Sussex have called for stronger protections for children online, warning that not enough is being done to shield young people from the dangers of social media

During a visit to New York, Prince Harry and Meghan Markle unveiled a new memorial dedicated to the memory of children whose families believe harmful online content contributed to their deaths. The installation, named the Lost Screen Memorial, features 50 smartphones, each displaying an image of a child lost to what their families describe as the adverse effects of social media. The memorial was made available to the public for 24 hours.

Keep ReadingShow less
Priyanka Chopra Teams Up with John Cena, Idris Elba in 'Heads of State'

An elite MI6 agent played by Priyanka Chopra Jonas

Getty

Priyanka Chopra fronts action thriller ‘Heads of State’ with John Cena, Idris Elba

A dynamic of action, comedy, and political misadventure is set to hit Prime Video this summer with the release of Heads of State. The newly launched trailer teases a fast-paced, explosive ride featuring Priyanka Chopra Jonas, John Cena, and Idris Elba in lead roles. The film is slated to premiere globally on 2 July 2025.

Directed by Ilya Naishuller, the filmmaker behind Hardcore Henry and Nobody, Heads of State is billed as a cross between Air Force One and Midnight Run. The film places mismatched world leaders at the centre of a chaotic crisis that forces them to work together, despite their egos and rivalries.

Keep ReadingShow less
Afghan exodus soars as Pakistan deadline nears

Afghan refugees arrive at a camp near the Torkham border last Sunday (20)

Afghan exodus soars as Pakistan deadline nears

MORE than 100,000 Afghans have left Pakistan in the past three weeks, the interior ministry said on Tuesday (22), after Islamabad announced the cancellation of residence permits.

Calling Afghans “terrorists and criminals”, the Pakistan government launched its mass eviction campaign on April 1. Analysts said the expulsions are designed to pressure Afghanistan’s Taliban authorities, which Islamabad blames for fuelling a rise in border attacks.

Keep ReadingShow less